Maravai LifeSciences (NASDAQ: MRVI)
Maravai LifeSciences Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Maravai LifeSciences Company Info
Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The Protein Detection segment is engaged in manufacturing and selling labeling and visual detection reagents to scientific research customers for their tissue-based protein detection and characterization needs. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.
News & Analysis
2 Healthcare Companies That Could Be Acquired Within 5 Years
These stocks are also cheap buys that are down more than 60% from their highs.
2 Biotech Stocks You Can Buy and Hold for the Next Decade
These two companies are facing short-term issues that are likely to give way to long-term success.
This Fallen Growth Stock Is Still a Wall Street Favorite: Here's Why
It's positioned to benefit from the emergence of a new, long-term trend in biopharma.
3 of the Best Bear Market Buys for August
Buying all three of these stocks would give you some great diversification in toys, tech, and healthcare.
Forget Robinhood and Buy These 2 Growth Stocks Instead
These shares have underperformed the market in the past year, but they could be winners over the long term.
1 Biotech Stock Investors Should Know About
It's selling shovels amid the gold rush in mRNA medicines.
Why Maravai LifeSciences Tumbled Nearly 12% Today
A private equity firm and several peers are cashing out of a pile of shares.
Valuation
Earnings Transcripts
Maravai LifeSciences (MRVI) Q4 2024 Earnings Call Transcript
MRVI earnings call for the period ending December 31, 2024.
Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript
MRVI earnings call for the period ending September 30, 2024.
Maravai LifeSciences (MRVI) Q2 2024 Earnings Call Transcript
MRVI earnings call for the period ending June 30, 2024.
Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript
MRVI earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.